Background: Salvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects. This study was conducted to examine the SM-induced anti-osteoporotic effect and its possible mechanisms with various doses of SM.Methods: We studied Sprague-Dawley female rats aged 12 weeks, divided into six groups: sham-operated control (SHAM), OVX rats supplemented with SM (1, 3, 10 and 30 mg/kg) orally for 8 weeks. At the end of the experiment, blood samples were collected and biochemistry analysis was performed. Specimens from both tibia and liver were processed for light microscopic examination. DEXA and μ-CT analyses of the tibia were also performed.Results: SM treatment significantly ameliorated the decrease in BMD and trabecular bone mass according to DEXA and trabecular bone architecture analysis of trabecular bone structural parameters by μ-CT scanning. In serum biochemical analysis, SM decreased the released TRAP-5b, an osteoclast activation marker and oxidative stress parameters including MDA and NO induced by OVX.Conclusions: The preventive effect of SM was presumably due to its anti-oxidative stress partly via modulation of osteoclast maturation and number. In current study, SM appears to be a promising osteoporosis therapeutic natural product. © 2011 Cui et al; licensee BioMed Central Ltd.
CITATION STYLE
Cui, Y., Bhandary, B., Marahatta, A., Lee, G. H., Li, B., Kim, D. S., … Chae, H. J. (2011). Characterization of Salvia Miltiorrhiza ethanol extract as an anti-osteoporotic agent. BMC Complementary and Alternative Medicine, 11. https://doi.org/10.1186/1472-6882-11-120
Mendeley helps you to discover research relevant for your work.